Warner Chilcott: Clinical Trials

32 trials sponsored by Warner Chilcott, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 1 terminated. 32 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 332Completed 31, Terminated 1

Follow Warner Chilcott: new trials by email

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia
WC3011 Estradiol Vaginal Cream, Vehicle - Vulvovaginal Atrophy
Phase 3CompletedWarner Chilcott5502013-04-122022-05-09
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
Vehicle, WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy
Phase 3CompletedWarner Chilcott5762013-01-312022-05-09
Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)
WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy
Phase 3CompletedWarner Chilcott3092011-10-202022-05-09
Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women
WC3011 Estradiol Vaginal Cream, Vehicle - Postmenopausal Vulvovaginal Atrophy
Phase 3CompletedWarner Chilcott7222011-06-292022-05-09
Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin
Doxycyline Hyclate tablet, Vibramycin (doxycyline hyclate) capsule - Urogential Chlamydia Trachomatis Infection
Phase 3CompletedWarner Chilcott4952010-04-012012-01-27
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy
Udenafil 50 mg, Udenafil 100 mg, Udenafil 150 mg - Erectile Dysfunction
Phase 3CompletedWarner Chilcott10272010-01-012015-04-20
Assessing the Safety/Efficacy of AsacolĀ® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
Asacol 400 mg - Ulcerative Colitis
Phase 3TerminatedWarner Chilcott392009-10-012012-05-25
Treatment of Erectile Dysfunction II
Udenafil, Placebo - Erectile Dysfunction
Phase 3CompletedWarner Chilcott6012009-09-012015-06-19
Treatment of Erectile Dysfunction I
Udenafil, Placebo - Erectile Dysfunction
Phase 3CompletedWarner Chilcott6182009-09-012011-12-22
Assessing the Safety/Efficacy of AsacolĀ® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
Asacol 400 mg - Ulcerative Colitis
Phase 3CompletedWarner Chilcott832008-12-012012-04-05
A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
risedronate - Postmenopausal Osteoporosis
Phase 3CompletedWarner Chilcott9232007-10-012013-04-22
A Comparison of Once a Day Dose Compared to 2 Doses/Day
Mesalamine Once-Daily, Mesalamine Twice-Daily - Ulcerative Colitis
Phase 3CompletedWarner Chilcott10272007-07-012013-04-22
Study of Safety and Efficacy of an Oral Contraceptive
Norethindrone/ethinyl estradiol - Contraception
Phase 3CompletedWarner Chilcott17002007-06-012013-04-22
Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
Testosterone Transdermal System, Placebo patch - Hypoactive Sexual Desire Disorder
Phase 3CompletedWarner Chilcott12712007-04-012011-12-15
Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
Testosterone, Placebo - Hypoactive Sexual Desire Disorder
Phase 3CompletedWarner Chilcott2722006-11-012013-04-17
Study of Safety and Efficacy of an Oral Contraceptive
Norethindrone acetate/ethinyl estradiol - Contraception
Phase 3CompletedWarner Chilcott16832006-11-012013-04-22
A Double Blind Study for the Treatment of Acute Ulcerative Colitis
Mesalamine - Ulcerative Colitis
Phase 3CompletedWarner Chilcott7722006-06-012013-04-17
Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method
Placebo comparator, risedronate - Osteopenia
Phase 3CompletedWarner Chilcott1612006-04-012012-01-11
A Study of Monthly Risedronate for Osteoporosis
risedronate - Postmenopausal Osteoporosis
Phase 3CompletedWarner Chilcott12942005-10-012013-04-22
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
risedronate sodium (Actonel), Placebo - Osteogenesis Imperfecta
Phase 3CompletedWarner Chilcott1432004-11-012013-04-22

Showing 20 of 32. Sign in to see all of them.

Conditions studied

Sexual Dysfunctions, Psychological (7)  ·  Colitis, Ulcerative (6)  ·  Erectile Dysfunction (3)  ·  Osteoporosis, Postmenopausal (3)  ·  Osteoporosis (2)  ·  Bone Diseases, Metabolic (1)  ·  Chlamydia Infections (1)  ·  Dyspareunia (1)  ·  Inflammatory Bowel Diseases (1)  ·  Osteogenesis Imperfecta (1)

Interventions

Risedronic Acid (7)  ·  Mesalamine (5)  ·  udenafil (3)  ·  Ethinyl Estradiol (2)  ·  Norethindrone Acetate (2)  ·  Testosterone (2)  ·  Capsules (1)  ·  Doxycycline (1)  ·  Estradiol (1)  ·  Estrogens, Conjugated (USP) (1)  ·  ovcon 35 (1)

Countries

United States (27)  ·  Canada (12)  ·  Australia (11)  ·  Poland (9)  ·  Belgium (5)  ·  Hungary (5)  ·  France (4)  ·  Spain (4)  ·  United Kingdom (4)  ·  Argentina (3)  ·  Croatia (3)  ·  Czechia (3)  ·  Estonia (3)  ·  Finland (3)  ·  Germany (3)

Top investigators

Herman Ellman, MD (8)  ·  Anna Chan, PharmD (4)  ·  Johna Lucas, MD (4)  ·  Dietrich H Wenderoth, MD (2)  ·  Piotr Krzeski, MD (2)  ·  Ana Balske, MD, PhD (1)  ·  Dietrich Wenderoth, MD (1)  ·  Gioacchino D'Alo, MD (1)  ·  Herman Ellman (1)  ·  Imran A Lodhi, MD (1)  ·  Jeffery Kralstein, MD (1)  ·  John Caminis, MD (1)  ·  Johna Lucus, MD (1)  ·  Preston M Dunnmon, MD (1)  ·  Sal Bartelmo, MD (1)

Results publications

PMID 21255059, PMID 21385195, PMID 18987368, PMID 20064514, PMID 21947137, PMID 22431798, PMID 22750403, PMID 23921878, PMID 23927913, PMID 25419597, PMID 26410176